Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Yi Zhou; Yantao Ding; Mengxing Cui; Yuanjing Zhang; Mengwei Wang; Feiran Zhou; Yi Su; Bo Liang; Fusheng Zhou

doi:10.12659/MSM.943360

08 May 2024 : Clinical Research

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Yi Zhou^123ACDE, Yantao Ding^123BCDE, Mengxing Cui^4F, Yuanjing Zhang^123BCD, Mengwei Wang^32B, Feiran Zhou^5F, Yi Su^6F, Bo Liang^123ACDG*, Fusheng Zhou^123ACD

DOI: 10.12659/MSM.943360

Med Sci Monit 2024; 30:e943360

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Distribution of lipid metabolites in the 2 assays(A, B) A total of 717 and 1145 lipids were identified in assays 1 and 2, respectively. (C, D). The shared 316 lipid metabolites and a total of 1,546 lipids in the 2 assays are shown in the pie plot. (Figures were generated by R with ggplot2_3.4.2.).

Back to the Article

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Your Privacy